Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Exploratory analysis of interleukin‐38 in hospitalized COVID‐19 patients

Immunity Inflammation and Disease(2022)10.1002/iid3.712Source: DataRank Database

Exploratory analysis of interleukin‐38 in hospitalized COVID‐19 patients is a research paper published in Immunity Inflammation and Disease (2022). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.08)OA: goldTopics (50)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Lisa U. Teufel ORCID,Aline H. de Nooijer,Adriaan J. van Gammeren ORCID,Antonius A.M. Ermens,Ildikó O. Gaál

Live enrichment

PubMed:36301025 PMC:PMC9601778 OpenAlex:https://openalex.org/W4307648853

European Research Council

Grant: #833247

European Research Council

Grant: 833247

Trained immunity: improving the next generation of vaccines for the older generation

NIAID NIH HHS

Grant: R01 AI015614

National Institutes of Health

Grant: 2R01AI015614-26

Pathogenesis of Fever in Humans

FWCI

0.08

Citation Percentile

0.4%

Citation Trend

2022

goldLicense: cc-by

journalhttps://doi.org/10.1002/iid3.712

publisherhttps://doi.org/10.1002/iid3.712

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/iid3.712

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/iid3.712

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36301025

Fields of Study

Psoriasis: Treatment and PathogenesisDermatology and Skin DiseasesInflammasome and immune disorders0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

COVID-19SARS-CoV-2Anti-Inflammatory AgentsFemaleHumansInterleukinsMaleRetrospective StudiesBiomarkersSerpins

Keywords

Coronavirus disease 2019 (COVID-19)Medicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PandemicInterleukinInterleukin 1βVirologyInternal medicineOutbreakCytokineDiseaseRetrospective Cohort StudyInterleukin-38Covid-19Sars-cov-2Radboudumc 4: lnfectious Diseases and Global Health RIMLS: Radboud Institute for Molecular Life SciencesMaleInterleukinsAnti-Inflammatory AgentsRadboud University Medical CenterOriginal ArticlesRC581-607SARS‐CoV‐2Radboudumc 2: Cancer development and immune defence RIMLS: Radboud Institute for Molecular Life SciencesCOVID‐19interleukin‐38HumansFemaleInternal Medicine - Radboud University Medical CenterImmunologic diseases. AllergyBiomarkersSerpinsRetrospective Studies

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Exploratory analysis of interleukin‐38 in hospitalized COVID‐19 patients

FAIR Checklist

Authors (12)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)